Nomoto, N.; Tate, S.; Arai, M.; Iizaka, S.; Mori, C.; Sakurai, K.
Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer. Nutrients 2022, 14, 5183.
https://doi.org/10.3390/nu14235183
AMA Style
Nomoto N, Tate S, Arai M, Iizaka S, Mori C, Sakurai K.
Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer. Nutrients. 2022; 14(23):5183.
https://doi.org/10.3390/nu14235183
Chicago/Turabian Style
Nomoto, Naoko, Shinichi Tate, Makoto Arai, Shinji Iizaka, Chisato Mori, and Kenichi Sakurai.
2022. "Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer" Nutrients 14, no. 23: 5183.
https://doi.org/10.3390/nu14235183
APA Style
Nomoto, N., Tate, S., Arai, M., Iizaka, S., Mori, C., & Sakurai, K.
(2022). Pretreatment Nutritional Status in Combination with Inflammation Affects Chemotherapy Interruption in Women with Ovarian, Fallopian Tube, and Peritoneal Cancer. Nutrients, 14(23), 5183.
https://doi.org/10.3390/nu14235183